loader
Please Wait
Applying Filters...

Athena Athena

X

Looking for Controlled & Modified Release? Find Poly DL Lactide, Poly DL Lactide co Glycolide , Poly L Lactide, Poly-DL-Lactic-co-Glycolic Acid, Polyethylene Glycol Excipient offered by Nomisma Healthcare for stability, solubility & bioavailability enhancement on PharmaCompass.

Previous
Next
Filters Filter
Cross PopUp
FILTER :

filter

01 Injectable / Parenteral (3)

02 Tablet (5)

filter

01 India (8)

Close
4

Applications:

PLLA-PEG used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.

Ingredient(s): Poly L Lactide, Polyethylene Glycol Excipient

Dosage Form: Tablet

Category: Controlled & Modified Release

Route of Administration (Grade): Oral, Parenteral
Pharmacopoeia Reference: NA

Technical Specifications: Nano-particles, ultrapure, low-monomer & powder grades

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

PLGA-PEG is used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.

Ingredient(s): Poly-DL-Lactic-co-Glycolic Acid, Polyethylene Glycol Excipients

Dosage Form: Tablet

Category: Controlled & Modified Release

Route of Administration (Grade): Oral, Parenteral
Pharmacopoeia Reference: NA

Technical Specifications: Nano-particles, ultrapure, low-monomer & powder grades.

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

PLLA

LM Application #LearnMore

Applications:

PLLA (Poly-L-lactide) is different polymer developed to formulate polymeric nanoparticles. PLLA is biodegradable & biocompatible, and it is approved by FDA and European Medicine Agency for parenteral administration.

Ingredient(s): Poly L Lactide

Dosage Form: Injectable / Parenteral, Tablet

Category: Controlled & Modified Release, Parenteral

Route of Administration (Grade): Oral, Parenteral
Pharmacopoeia Reference: NA

Technical Specifications: Nano-particles, ultrapure, low-monomer & powder grades, viscosity range from 0.08 to 1.4 dL/g, ester/acid end group

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

PDLLA

LM Application #LearnMore

Applications:

PDLLA (Poly-DL-lactide) is different polymers developed to formulate polymeric nanoparticles. PDLLA is biodegradable & biocompatible, and it has the FDA and EMA approval in drug delivery systems for parenteral administration.

Ingredient(s): Poly DL Lactide

Dosage Form: Injectable / Parenteral, Tablet

Category: Controlled & Modified Release, Parenteral

Route of Administration (Grade): Oral, Parenteral
Pharmacopoeia Reference: NA

Technical Specifications: Nano-particles, ultrapure, low-monomer & powder grades, viscosity range from 0.08 to 1.4 dL/g, ester/acid end group

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

PLGA

LM Application #LearnMore

Applications:

PLGA (Poly (Lactic-Co-Glycolic Acid)) is a unique base polymer for controlled release of drugs & medical implant materials. It is biodegradable & biocompatible and since both monomers occur naturally it has minimal toxicity.

Ingredient(s): Poly DL Lactide co Glycolide

Dosage Form: Injectable / Parenteral, Tablet

Category: Controlled & Modified Release, Parenteral

Route of Administration (Grade): Oral, Parenteral
Pharmacopoeia Reference: NA

Technical Specifications: Nano-particles, ultrapure, low-monomer & powder grades, available ratio PLGA 50:50, PLGA 75:25, PLGA 85:15, PLGA 55:45 Star Glucose, PLGA 65:35, PLGA 90:10.

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Post Enquiry
POST ENQUIRY